Skip to main content
Livermore
Livermore
ZHEN

Rafferty Asset Management, LLC

SEC CIK
0001389426
Latest filing
Aug 14, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of AVXL by Rafferty Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−143,750−100.0%Sold outHolders
Q1 2026143,750$441.3K<0.1%−12,551−8.0%ReducedHolders
Q4 2025156,301$556.4K<0.1%+47,873+44.2%AddedHolders
Q3 2025108,428$965.0K<0.1%+16,284+17.7%AddedHolders
Q2 202592,144$849.6K<0.1%−35,310−27.7%ReducedHolders
Q1 2025127,454$1.09M<0.1%+52,853+70.8%AddedHolders
Q4 202474,601$801.2K<0.1%−64,985−46.6%ReducedHolders
Q3 2024139,586$792.8K<0.1%−84,728−37.8%ReducedHolders
Q2 2024224,314$946.6K<0.1%−445,631−66.5%ReducedHolders
Q1 2024669,945$3.41M<0.1%+437,914+188.7%AddedHolders
Q4 2023232,031$2.16M<0.1%−38,757−14.3%ReducedHolders
Q3 2023270,788$1.77M<0.1%−79,874−22.8%ReducedHolders
Q2 2023350,662$2.85M<0.1%−114,593−24.6%ReducedHolders
Q1 2023465,255$3.99M<0.1%+501+0.1%AddedHolders
Q4 2022464,754$4.30M<0.1%+189,808+69.0%AddedHolders
Q3 2022274,946$2.84M<0.1%+107,130+63.8%AddedHolders
Q2 2022167,816$1.68M<0.1%−200,283−54.4%ReducedHolders
Q1 2022368,099$4.53M<0.1%+125,185+51.5%AddedHolders
Q4 2021242,914$4.21M<0.1%+76,282+45.8%AddedHolders
Q3 2021166,632$2.99M<0.1%−1,657−1.0%ReducedHolders
Q2 2021168,289$3.85M<0.1%+49,312+41.4%AddedHolders
Q1 2021118,977$1.78M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.